We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bupa to Buy Quality Healthcare Medical Services

By HospiMedica International staff writers
Posted on 28 Oct 2013
Fortis Healthcare (Gurgaon, India) has decided to sell its stake in Quality Healthcare Medical Services (QHMS; Hong Kong) to British medical services group BUPA (London, United Kingdom), as part of its efforts to reduce debt.

Established in 1868, QHMS is the largest provider of healthcare services to corporations in Hong Kong, with a network of 50 medical centers, more than 500 affiliated clinics, and more than 20 dental and physiotherapy centers. More...
QHMS was bought by a vehicle owned by Fortis founders Malvinder Mohan Singh and his brother Shivinder in October 2010 for about USD 190 million; in 2011, Fortis acquired all the international operations of the family business. The recent acquisition will make BUPA the leading healthcare funder and provider (in terms of depth and breadth of service) in Hong Kong, with a strong platform for future growth in the region.

The divestment, which will add USD 355 million to Fortis Healthcare’s depleted coffers, follows a similar divestment of its Australian dental corporation to BUPA for AUD 270 million in May 2013, and the sale of its stake in Hoan My Medical (Ho Chi Minh City, Vietnam) to Viva Holdings for a total consideration of USD 80 million. According to the company, the divestments are intended to help the company focus on its hospital and diagnostic business in India and further strengthen its balance sheet by improving its net debt to equity ratio and creating further room for growth.

“Quality HealthCare is a successful, well managed business that has a great future with BUPA. We both share a strong and common vision of providing high quality and affordable healthcare to people in Hong Kong,” said Stuart Fletcher, CEO of BUPA, said. “Together, we will be completely focused on delivering Bupa’s purpose of longer, healthier, happier lives to millions more people in Hong Kong.”

“Joining BUPA is an exciting step in Quality HealthCare's growth and evolution,” said Paul Li, CEO of of QHMS. “By combining our experience of delivering care to millions of people in Hong Kong with BUPA's international expertise in healthcare, we will continue to grow our business and provide access to high quality healthcare to our family of customers in Hong Kong.”

Fortis Healthcare is a leading integrated healthcare delivery provider in Asia, with interests panning diagnostics, primary care, day care specialty, and hospitals. The company has an asset base in 11 countries, including Australia, Canada, UAE, Hong Kong, India, Mauritius, Nepal, New Zealand, Singapore, and Sri Lanka.

Related Links:

Fortis Healthcare
Quality Healthcare Medical Services
BUPA



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.